– The study primary endpoint was met, showing non-inferiority vs. standard antimicrobial regimen in fungal free survival at Day 90...
Potent antibacterial activity against Gram-negative community and hospital-acquired infections highlighted across eight posters and two presentationSEDMONTON, Alberta , April 19,...
Strong global consensus on measurement and role of ammonia in Hepatic Encephalopathy (HE)Phase 2a results of YAQ007 (oral OPA) show...
Sales Highlights (unaudited): Global Q3 sales AUD$1.5 million up 16% on prior comparative period (pcp)YTD Mar 2026 sales AUD$5.7 million...
Project aims to develop a scalable manufacturing process and represents a key next step toward the commercialization of the surface...
Phase two collaboration aims to expand access to streamlined genomic workflows for infectious disease researchSUNNYVALE, Calif. and OXFORD, England, April 15,...
Modeling Shows Adoption of New Access MeMed BV Assay Could Cut up to €80M in Avoidable Costs across European Health Systems...
EDMONTON, Alberta , April 09, 2026 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc., a leader in the development of drugs to...
FORT LAUDERDALE, FL / ACCESS Newswire / April 6, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) ("Sunshine Biopharma" or the "Company"),...
Code assignment supports billing clarity and claims reporting for Imbed's synthetic antimicrobial wound matrix with localized, non-opioid pain managementMIDDLETON, Wis.,...
CHICAGO, IL / ACCESS Newswire / April 1, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a...
Kane also signs U.S.-based contract sales agentsWINNIPEG, Manitoba, March 10, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (Kane or the...
Expanding access to advanced PCR thermocyclers, DNA & RNA purification systems, and hematology analyzers for modern clinical laboratories SINGAPORE, SG...
Registration marks the Company’s entry into the UK market, where H. pylori affects an estimated 45% of the population across...
The growing prevalence of infectious diseases, increasing antimicrobial resistance (AMR), and the rising demand for rapid diagnostic solutions are the...
NEW YORK, Feb. 24, 2026 /PRNewswire/ -- disAMR, a new company formed by partners who built Brammer Bio and have worked...
GARDEN CITY, N.Y., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a...
WINNIPEG, Manitoba, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE) (“Kane Biotech” or “Kane”) announces the publication...
Greenhouse trial results published jointly with USDA-ARS demonstrate 76-98% reduction in aflatoxin contamination in transgenic corn expressing the BioCypher-designed peptide...
Greenhouse trial results published jointly with USDA-ARS demonstrate 76-98% reduction in aflatoxin contamination in transgenic corn expressing the BioCypher-designed peptide...